EMPALIX L (25/5)
Composition: Empagliflozin 25 mg + Linagliptin 5 mg. View EMPALIX L (25/5) details or enquire about availability and franchise supply.
EMPALIX L (25/5) product overview
EMPALIX L (25/5) contains Empagliflozin 25 mg + Linagliptin 5 mg. The product is listed in Positive Medicare’s Diabexa division and diabetic range. The composition is shown clearly for pharmaceutical distributors, healthcare trade professionals and franchise applicants who need to identify the exact formulation before requesting business details.
Composition
- Empagliflozin 25 mg
- Linagliptin 5 mg
Availability and franchise enquiries
Contact the Positive Medicare team for the latest pack presentation, order quantity, territory status and commercial terms. Prospective partners can review the diabetic PCD pharma franchise opportunity or submit an enquiry about third-party pharmaceutical manufacturing.
Important: This page is intended for healthcare professionals and pharmaceutical business enquiries. It does not provide treatment advice. Prescription products should be used only under a registered healthcare professional’s direction and according to approved product labelling.
Related products
LINANTA M 500
